Low dose intrathecal morphine in thoracic surgery

Low dose intrathecal morphine in thoracic surgery, a retrospective analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210507002

Enrollment

162

Registered

2021-05-07

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic, non-cardiac surgery thoracic surgery, intrathecal morphine, sternotomy, VATS

Interventions

Intraoperative got intrathecal morphine 0.1 mg,Intraoperative got intrathecal morphine 0.2 mg

Treatment,Treatment

intrathecal morphine 0.1 mg,intrathecal morphine 0.2 mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: elective thoracic surgery

Exclusion criteria

Exclusion criteria: preoperative intubation, reoperation or reintubation within 48h after the procedure, missing data

Design outcomes

Primary

Measure	Time frame
morphine consumption 24h amount of morphine	—

Secondary

Measure	Time frame
24-48h morphine consumption 24-48h mg,adverse events 48h percent occured,pain score at rest and at movement 24h numerical rating scale, NRS,pain score at rest and at movement 48h numerical rating scale, NRS	—

Countries

Thailand

Contacts

Public ContactThanaphon Srimueang

Khon Kaen University, Thailand

srthana@kku.ac.th0897130614

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026